- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SMG buys Ziegler refurbishing center
Ziegler Medical Equipment has completed its exit from operatingits own equipment refurbishing business by selling its Omaha refurboperation to Shared Medical Equipment Group, also of Omaha. Ziegler president Thomas Norman announced last month that
Ziegler Medical Equipment has completed its exit from operatingits own equipment refurbishing business by selling its Omaha refurboperation to Shared Medical Equipment Group, also of Omaha.
Ziegler president Thomas Norman announced last month that Zieglerhad decided to scale back its investment in refurbishing equipmentdue to aggressive OEM price slashing on new equipment, which wascutting into used equipment sales. The West Bend, WI, companyhalted its effort to enlarge its direct sales force for refurbishedequipment and said it was in negotiations to sell its Omaha refurbishingcenter (SCAN 7/31/96). Ziegler will continue to sell pre-ownedequipment.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
